Raleigh Capital Management’s Insulet PODD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-58
Closed -$15.1K – 918
2024
Q4
$15.1K Sell
58
-15
-21% -$3.78K 0.01% 520
2024
Q3
$17K Sell
73
-2
-3% -$411 0.01% 473
2024
Q2
$15.2K Buy
75
+40
+114% +$7.21K 0.01% 485
2024
Q1
$6K Sell
35
-285
-89% -$53.1K ﹤0.01% 631
2023
Q4
$69.4K Buy
+320
New +$54.9K 0.03% 247
2023
Q3
– Sell
-54
Closed -$15.6K – 1003
2023
Q2
$15.6K Buy
+54
New +$16.4K 0.01% 418
2022
Q4
– Sell
-13
Closed -$3K – 869
2022
Q3
$3K Buy
+13
New +$3.26K ﹤0.01% 605

Other funds holding PODD

Raleigh Capital Management's PODD Position: Q1 2025 in Review

Raleigh Capital Management sold out of Insulet (PODD) in Q1 2025, closing a stake of 58 shares — an estimated $15.1K sold.

Raleigh Capital Management first reported a position in PODD in Q3 2022 and held it in 7 quarters. The position peaked at $69.4K in Q4 2023. 719 funds tracked by Wall St. Rank hold PODD as of Q1 2025.

  • Raleigh Capital Management reported no remaining Insulet position as of Q1 2025 after selling out during the quarter.
  • Raleigh Capital Management sold 58 Insulet shares in Q1 2025, an estimated $15.1K.
  • Raleigh Capital Management first reported a position in Insulet in Q3 2022 and held it in 7 quarters.
  • Raleigh Capital Management's Insulet position peaked at $69.4K in Q4 2023.
  • 719 funds tracked by Wall St. Rank held Insulet as of Q1 2025.

Based on Raleigh Capital Management's 13F filing for Q1 2025, filed 29 Apr 2025.